These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

DeepSeek’s recent claim that it can make artificial intelligence less power-hungry is just the latest reason the energy ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.

While Ozempic did help Amy Schumer lose weight rapidly, it came at a cost as she suffered from nausea and exhaustion ...

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

Fourteen members of a small religious sect in Australia have been found guilty of the manslaughter of an 8-year-old girl, who ...

The latest statistics were revealed in the American Heart Association’s annual report, 2025 Heart Disease and Stroke ...